Overexpression of stathmin/oncoprotein 18 correlates with poorer prognosis and interacts with p53 in oral squamous cell carcinoma
- 1 October 2016
- journal article
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 44 (10) , 1725-1732
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81430012)
This publication has 25 references indexed in Scilit:
- Oral cavity and oropharyngeal squamous cell carcinoma—an updateCA: A Cancer Journal for Clinicians, 2015
- Neck recurrence of oral squamous cell carcinoma in unusual sites: Retrospective study of 1658 casesHead & Neck, 2015
- Elevated p53 expression levels correlate with tumor progression and poor prognosis in patients exhibiting esophageal squamous cell carcinomaOncology Letters, 2014
- RNAi-mediated stathmin suppression reduces lung metastasis in an orthotopic neuroblastoma mouse modelOncogene, 2013
- Oral complications of cancer and cancer therapyCA: A Cancer Journal for Clinicians, 2012
- Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosisBritish Journal of Cancer, 2006
- The oncoprotein 18/stathmin family of microtubule destabilizersCurrent Opinion in Cell Biology, 2002
- p53-mediated negative regulation of stathmin/Op18 expression is associated with G2/M cell-cycle arrestInternational Journal of Cancer, 2000
- Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 inductionOncogene, 1999
- Stathmin: A Tubulin-Sequestering Protein Which Forms a Ternary T2S Complex with Two Tubulin MoleculesBiochemistry, 1997